NCT00882089View on ClinicalTrials.gov

Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Breast Cancer
Interventions
DEVICE

Contura catheter

Radiation therapy is delivered to a total dose of 34 Gy in 10 fractions bid over 5-7 days. Each day, the high dose rate iridium-192 brachytherapy treatments are separated by 6 hours. Each radiation treatment takes 15-30 minutes.

Trial Locations (1)

92618

Cancer Center of Irvine, Irvine

All Listed Sponsors
collaborator

SenoRx, Inc.

INDUSTRY

lead

Cancer Center of Irvine

OTHER

NCT00882089 - Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients | Biotech Hunter | Biotech Hunter